Impetigo: A need for new therapies in a world of increasing antimicrobial resistance.
What is known and objective Impetigo is a highly contagious bacterial skin infection and is one of the most common skin infections in children. Antibiotics are the first-line treatment when multiple lesions exist, but with an increasing prevalence of antibiotic-resistant bacteria the successful mana...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 43; no. 1; pp. 150 - 154 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
Wiley-Blackwell
Feb2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=127063646&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 127063646 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 02694727 EV4 jtl: Journal of Clinical Pharmacy & Therapeutics issn: 02694727 maglogo: Y pubinfo: dt: Feb2018 vid: 43 iid: 1 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 127063646 10.1111/jcpt.12639 127063646 ppf: 150 ppct: 4 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Impetigo: A need for new therapies in a world of increasing antimicrobial resistance. aug: au: D'Cunha, N. M. Peterson, G. M. Baby, K. E. Thomas, J. affil: Faculty of Health, University of Canberra, Bruce, ACT, Australia sug: subj: Impetigo Drug Therapy Drug Resistance, Microbial Administration, Oral Administration, Topical Antiinfective Agents, Local Treatment Outcomes Fusidic Acid Mupirocin ab: What is known and objective Impetigo is a highly contagious bacterial skin infection and is one of the most common skin infections in children. Antibiotics are the first-line treatment when multiple lesions exist, but with an increasing prevalence of antibiotic-resistant bacteria the successful management of impetigo in the future is an area of concern. Comment Current treatment options that favour the use of oral antibiotic therapy are increasingly problematic. Widespread use of these agents contributes to antimicrobial resistance and has adverse consequences for individuals and communities. There is a need for new topical antimicrobials and antiseptics as an alternative treatment strategy. What is new and conclusion To successfully treat impetigo into the future and ensure that therapy does not contribute to bacterial resistance, additional research is required to ascertain the usefulness of alternative agents, including new topical antimicrobials and antiseptics. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|